GLP-1NEW RESEARCH
New research reveals that about 10% of people may have ‘GLP-1 resistance’ due to specific genetic variants, making drugs like Ozempic and Wegovy less effective. These individuals appear to produce higher levels of certain compounds that interfere with the medication’s effectiveness.